Dr. Georgeanne Botek, DPM, is a podiatrist who has been part of the Cleveland Clinic’s Department of Orthopaedic Surgery ...

The investigators conducted a prospective interventional study to determine the therapeutic anatomic and functional effects ...

The FDA approved an expanded label for Iluvien, which is now indicated for the treatment of chronic noninfectious uveitis ...

Alcon acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Terms of the deal weren't disclosed.

UNITY anticipates the complete 36-week data results of the remaining patients in the second quarter of 2025.

Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partner’s New Drug Application for ARCATUS® (XIPERE®) for Uveitic Macular Edema ...